Both in Pharmaceuticals
Altimmune vs CorMedix
Over the past year ALT returned −49.0% and CRMD returned −53.3%; their daily moves had a correlation of 0.23.
ALT −49.0% CRMD −53.3%Growth of $1, one year, split-adjusted
| Metric | ALT | CRMD |
|---|---|---|
| Price | $2.02 | $5.39 |
| Market cap | $392.9M | $420.1M |
| Today | −0.98% | −5.36% |
| 1 month | −26.1% | −25.0% |
| 6 months | −33.1% | −31.8% |
| Year to date | −44.0% | −53.7% |
| 1 year | −50.4% | −53.6% |
| Revenue growth (YoY) | −100.0% | +156.5% |
| Gross margin | — | 75.7% |
| Net margin | — | 25.5% |
| P/E (TTM) | — | 2.2× |
| Price / sales | 12,675.0× | 0.9× |
| Net cash | $291.5M | $256.7M |
| Dividend yield | — | — |
| Volatility (60d) | 46.8% | 77.1% |
| Short % of float | 22.2% | 20.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).